GDF15 and metabolic dysfunction-associated steatotic liver disease: In humans, increased liver mRNA and plasma levels of GDF15 are found in individuals with MASLD (Koo et al., 2018), whereas circulating GDF15 is also increased in obese and T2DM patients (Wang et al., 2021).